{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:10:45Z","timestamp":1784257845491,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Core Research Grant, DST-SERB","award":["CRG\/2020\/005175"],"award-info":[{"award-number":["CRG\/2020\/005175"]}]},{"name":"Core Research Grant, DST-SERB","award":["CRG\/2020\/005175"],"award-info":[{"award-number":["CRG\/2020\/005175"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11912-024-01623-5","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T01:22:00Z","timestamp":1736299320000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma"],"prefix":"10.1007","volume":"27","author":[{"given":"Nikita","family":"Mehra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhiksha","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunagiri Kuha Deva Magendhra","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"8","key":"1623_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrclinonc.2011.63","volume":"8","author":"SV Rajkumar","year":"2011","unstructured":"Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol. 8(8):479\u201391. https:\/\/doi.org\/10.1038\/nrclinonc.2011.63","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"1623_CR2","first-page":"853","volume":"78","author":"KC Nau","year":"2008","unstructured":"Nau KC, Lewis WD. Multiple Myeloma: Diagnosis and treatment. Am Fam Physician. 2008;78(7):853\u20139.","journal-title":"Am Fam Physician."},{"key":"1623_CR3","doi-asserted-by":"publisher","unstructured":"Bray F et al. \u2018Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries\u2019, CA. Cancer J. Clin., vol. n\/a, no. n\/a, https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"issue":"9","key":"1623_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrclinonc.2012.128","volume":"9","author":"SV Rajkumar","year":"2012","unstructured":"Rajkumar SV, Merlini G, San Miguel JF. Redefining myeloma. Nat Rev Clin Oncol. 9(9):494\u20136. https:\/\/doi.org\/10.1038\/nrclinonc.2012.128.","journal-title":"Nat Rev Clin Oncol"},{"issue":"22","key":"1623_CR5","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study. Blood. 2009;113(22):5412\u20137. https:\/\/doi.org\/10.1182\/blood-2008-12-194241.","journal-title":"Blood"},{"issue":"10","key":"1623_CR6","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1038\/bcj.2015.92","volume":"5","author":"AM Rajan","year":"2015","unstructured":"Rajan AM, Rajkumar SV. Interpretation of cytogenetic results in multiple myeloma for clinical practice. Blood Cancer J. 5(10):e365. https:\/\/doi.org\/10.1038\/bcj.2015.92.","journal-title":"Blood Cancer J"},{"issue":"1","key":"1623_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41375-019-0543-4","volume":"34","author":"K Misund","year":"2020","unstructured":"Misund K, et al. MYC dysregulation in the progression of multiple myeloma. Leukemia. 2020;34(1):322\u20136. https:\/\/doi.org\/10.1038\/s41375-019-0543-4.","journal-title":"Leukemia."},{"issue":"6","key":"1623_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker BA, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma\u2019. Blood. 2018;132(6):587\u201397. https:\/\/doi.org\/10.1182\/blood-2018-03-840132.","journal-title":"Blood."},{"issue":"7","key":"1623_CR9","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/cancers13071668","volume":"13","author":"L John","year":"2021","unstructured":"John L, Krauth MT, Podar K, Raab M-S. \u2018Pathway-directed therapy in multiple myeloma. Cancers. 2021;13(7):1668. https:\/\/doi.org\/10.3390\/cancers13071668.","journal-title":"Cancers"},{"issue":"6","key":"1623_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s12185-022-03353-5","volume":"115","author":"I Hanamura","year":"2022","unstructured":"Hanamura I. Multiple myeloma with high-risk cytogenetics and its treatment approach. Int J Hematol. 2022;115(6):762\u201377. https:\/\/doi.org\/10.1007\/s12185-022-03353-5.","journal-title":"Int J Hematol"},{"issue":"5","key":"1623_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.gde.2005.08.002","volume":"15","author":"F Fuks","year":"2005","unstructured":"Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005;15(5):490\u20135. https:\/\/doi.org\/10.1016\/j.gde.2005.08.002.","journal-title":"Curr Opin Genet Dev."},{"issue":"7","key":"1623_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1101\/gad.1787609","volume":"23","author":"SL Berger","year":"2009","unstructured":"Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781\u20133. https:\/\/doi.org\/10.1101\/gad.1787609.","journal-title":"Genes Dev"},{"issue":"1","key":"1623_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2010","unstructured":"Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27\u201336. https:\/\/doi.org\/10.1093\/carcin\/bgp220.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1623_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/bjh.13506","volume":"172","author":"JI Sive","year":"2016","unstructured":"Sive JI, Feber A, Smith D, Quinn J, Beck S, Yong K. Global hypomethylation in myeloma is associated with poor prognosis. Br J Haematol. 2016;172(3):473\u20135. https:\/\/doi.org\/10.1111\/bjh.13506.","journal-title":"Br J Haematol"},{"issue":"10","key":"1623_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/sj.leu.2403434","volume":"18","author":"O Galm","year":"2004","unstructured":"Galm O, et al. DNA methylation changes in multiple myeloma. Leukemia. 2004;18(10):1687\u201392. https:\/\/doi.org\/10.1038\/sj.leu.2403434.","journal-title":"Leukemia."},{"issue":"6","key":"1623_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/sj.leu.2404205","volume":"20","author":"C-S Chim","year":"2006","unstructured":"Chim C-S, Liang R, Leung M-H, Yip S-F, Kwong Y-L. Aberrant gene promoter methylation marking disease progression in multiple myeloma. Leukemia. 2006;20(6):1190\u20132. https:\/\/doi.org\/10.1038\/sj.leu.2404205.","journal-title":"Leukemia"},{"issue":"17","key":"1623_CR17","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1158\/0008-5472.CAN-10-0282","volume":"70","author":"B Salhia","year":"2010","unstructured":"Salhia B, Baker A, Ahmann G, Auclair D, Fonseca R, Carpten J. DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors. Cancer Res. 2010;70(17):6934\u201344. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0282.","journal-title":"Cancer Res"},{"issue":"10","key":"1623_CR18","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.3390\/cancers12102996","volume":"12","author":"C Caprio","year":"2020","unstructured":"Caprio C, Sacco A, Giustini V, Roccaro AM. Epigenetic aberrations in multiple myeloma. Cancers. 2020;12(10):2996. https:\/\/doi.org\/10.3390\/cancers12102996.","journal-title":"Cancers"},{"issue":"17","key":"1623_CR19","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.1073\/pnas.0908441107","volume":"107","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, et al. High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2\/AGO2. Proc Natl Acad Sci U S A. 2010;107(17):7904\u20139. https:\/\/doi.org\/10.1073\/pnas.0908441107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1745-6150-6-23","volume":"6","author":"J Chi","year":"2011","unstructured":"Chi J, et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct. 6:23. https:\/\/doi.org\/10.1186\/1745-6150-6-23.","journal-title":"Biol Direct"},{"issue":"5","key":"1623_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1365-2141.2011.08782.x","volume":"154","author":"K-Y Wong","year":"2011","unstructured":"Wong K-Y, Liang R, So C-C, Jin D-Y, Costello JF, Chim C-S. Epigenetic silencing of MIR203 in multiple myeloma. Br J Haematol. 2011;154(5):569\u201378. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08782.x.","journal-title":"Br J Haematol"},{"issue":"2","key":"1623_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ncrna9020027","volume":"9","author":"E Bayraktar","year":"2023","unstructured":"Bayraktar E, Bayraktar R, Oztatlici H, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C. Targeting mirnas and other non-coding rnas as a therapeutic approach: An update. Non-Coding RNA. 2023;9(2):27. https:\/\/doi.org\/10.3390\/ncrna9020027.","journal-title":"Non-Coding RNA."},{"issue":"12","key":"1623_CR23","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/s41375-018-0116-y","volume":"32","author":"MK Samur","year":"2018","unstructured":"Samur MK, et al. Long intergenic non-coding rnas have an independent impact on survival in multiple myeloma. Leukemia. 2018;32(12):2626\u201335. https:\/\/doi.org\/10.1038\/s41375-018-0116-y.","journal-title":"Leukemia."},{"issue":"5","key":"1623_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1101\/gr.6036807","volume":"17","author":"J Ponjavic","year":"2007","unstructured":"Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 17(5):556\u201365. https:\/\/doi.org\/10.1101\/gr.6036807.","journal-title":"Genome Res"},{"issue":"1","key":"1623_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12870-017-0984-8","volume":"17","author":"Q Xu","year":"2017","unstructured":"Xu Q, et al. Systematic comparison of lncRNAs with protein coding mRNAs in population expression and their response to environmental change. BMC Plant Biol. 17(1):42. https:\/\/doi.org\/10.1186\/s12870-017-0984-8.","journal-title":"BMC Plant Biol"},{"key":"1623_CR26","doi-asserted-by":"publisher","unstructured":"Zhou ZX, Chen XM, Zhang YQ, Peng L, Xue XY, Li GX. Comprehensive analysis of long noncoding RNA and mRNA in five colorectal cancer tissues and five normal tissues. Bio Rep. 2020;40(2):BSR20191139. https:\/\/doi.org\/10.1042\/BSR20191139","DOI":"10.1042\/BSR20191139"},{"issue":"12","key":"1623_CR27","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.3390\/ijms18122659","volume":"18","author":"C Wang","year":"2017","unstructured":"Wang C, et al. LncRNA structural characteristics in epigenetic regulation. Int J Mol Sci. 18(12):2659. https:\/\/doi.org\/10.3390\/ijms18122659.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1623_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/ijms19020570","volume":"19","author":"M Morlando","year":"2018","unstructured":"Morlando M, Fatica A. Alteration of epigenetic regulation by long noncoding rnas in\u00a0cancer. Int J Mol Sci. 2018;19(2):570. https:\/\/doi.org\/10.3390\/ijms19020570.","journal-title":"Int J Mol Sci."},{"issue":"11","key":"1623_CR29","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.3390\/cancers12113220","volume":"12","author":"M Aprile","year":"2020","unstructured":"Aprile M, Katopodi V, Leucci E, Costa V. LncRNAs in cancer: From garbage to junk. Cancers. 2020;12(11):3220. https:\/\/doi.org\/10.3390\/cancers12113220.","journal-title":"Cancers"},{"key":"1623_CR30","doi-asserted-by":"publisher","first-page":"1067406","DOI":"10.3389\/fmolb.2022.1067406","volume":"9","author":"Z Yang","year":"2022","unstructured":"Yang Z, et al. Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. Front Mol Biosci. 9:1067406. https:\/\/doi.org\/10.3389\/fmolb.2022.1067406.","journal-title":"Front Mol Biosci"},{"issue":"11","key":"1623_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/bies.201100084","volume":"33","author":"A Saxena","year":"2011","unstructured":"Saxena A, Carninci P. Long non-coding RNA modifies chromatin. Bio Essays. 2011;33(11):830\u20139. https:\/\/doi.org\/10.1002\/bies.201100084.","journal-title":"Bio Essays"},{"key":"1623_CR32","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-16-0356","volume":"76","author":"M Sun","year":"2016","unstructured":"Sun M, et al. LncRNA hoxa11-as promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors prc2, lsd1, and dnmt1. Cancer Res. 76:6299\u2013310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0356.","journal-title":"Cancer Res"},{"issue":"7620","key":"1623_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, et al. m6A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369\u201373. https:\/\/doi.org\/10.1038\/nature19342.","journal-title":"Nature"},{"issue":"1","key":"1623_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/genes10010052","volume":"10","author":"S Dinescu","year":"2019","unstructured":"Dinescu S, Ignat S, Lazar AD, Constantin C, Neagu M, Costache M. Epitranscriptomic signatures in lncRNAs and their possible roles in cancer. Genes. 2019;10(1):52. https:\/\/doi.org\/10.3390\/genes10010052.","journal-title":"Genes."},{"issue":"8","key":"1623_CR35","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/cancers14081963","volume":"14","author":"I Saltarella","year":"2022","unstructured":"Saltarella I, et al. The landscape of lncRNAs in multiple myeloma: Implications in the hallmarks of cancer, clinical perspectives and therapeutic opportunities. Cancers. 2022;14(8):1963. https:\/\/doi.org\/10.3390\/cancers14081963.","journal-title":"Cancers"},{"issue":"2","key":"1623_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00432-020-03127-8","volume":"146","author":"N Liu","year":"2020","unstructured":"Liu N, Feng S, Li H, Chen X, Bai S, Liu Y. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis. J Cancer Res Clin Oncol. 2020;146(2):367\u201379. https:\/\/doi.org\/10.1007\/s00432-020-03127-8.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1623_CR37","doi-asserted-by":"publisher","unstructured":"Stamato MA et al. Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma. Oncotarget. 2017;8:106527-106537. https:\/\/doi.org\/10.18632\/oncotarget.22507","DOI":"10.18632\/oncotarget.22507"},{"issue":"2","key":"1623_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-018-1219-0","volume":"10","author":"Y Pan","year":"2019","unstructured":"Pan Y, et al. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Cell Death Dis. 2019;10(2):106. https:\/\/doi.org\/10.1038\/s41419-018-1219-0.","journal-title":"Cell Death Dis."},{"issue":"04","key":"1623_CR39","doi-asserted-by":"publisher","first-page":"788","DOI":"10.4149\/neo_2021_210205N184","volume":"68","author":"L-H Yang","year":"2021","unstructured":"Yang L-H, et al. \u2018LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN. Neoplasma. 2021;68(04):788\u201397. https:\/\/doi.org\/10.4149\/neo_2021_210205N184.","journal-title":"Neoplasma"},{"issue":"2","key":"1623_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3324\/haematol.2023.282965","volume":"109","author":"P Nylund","year":"2024","unstructured":"Nylund P, et al. PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma. Haematologica. 2024;109(2):567\u201377. https:\/\/doi.org\/10.3324\/haematol.2023.282965.","journal-title":"Haematologica"},{"issue":"1","key":"1623_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13046-022-02319-z","volume":"41","author":"W Huang","year":"2022","unstructured":"Huang W, Li H, Yu Q, Xiao W, Wang DO. LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond. J Exp Clin Cancer Res. 41(1):100. https:\/\/doi.org\/10.1186\/s13046-022-02319-z.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1623_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1623_CR43","doi-asserted-by":"publisher","first-page":"102058","DOI":"10.1016\/j.omtn.2023.102058","volume":"34","author":"J Yin","year":"2023","unstructured":"Yin J, et al. Systematic analysis of DNA methylation-mediated TF dysregulation on lncRNAs reveals critical roles in tumor immunity. Mol Ther - Nucleic Acids. 34. https:\/\/doi.org\/10.1016\/j.omtn.2023.102058.","journal-title":"Mol Ther - Nucleic Acids"},{"issue":"3","key":"1623_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/cancers13030365","volume":"13","author":"T Jakobsen","year":"2021","unstructured":"Jakobsen T, Dahl M, Dimopoulos K, Gr\u00f8nb\u00e6k K, Kjems J, Kristensen LS. \u2018Genome-wide circular rna expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells. Cancers. 2021;13(3):365. https:\/\/doi.org\/10.3390\/cancers13030365.","journal-title":"Cancers"},{"issue":"5","key":"1623_CR45","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41375-021-01147-y","volume":"35","author":"A Carrasco-Leon","year":"2021","unstructured":"Carrasco-Leon A, et al. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia. 2021;35(5):1438\u201350. https:\/\/doi.org\/10.1038\/s41375-021-01147-y.","journal-title":"Leukemia"},{"issue":"1","key":"1623_CR46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12935-020-01504-4","volume":"20","author":"Z Li","year":"2020","unstructured":"Li Z, et al. Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination. Cancer Cell Int. 20(1):403. https:\/\/doi.org\/10.1186\/s12935-020-01504-4.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1623_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-021-02209-w","volume":"41","author":"Z Wang","year":"2022","unstructured":"Wang Z, et al. Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance. J Exp Clin Cancer Res. 2022;41(1):4. https:\/\/doi.org\/10.1186\/s13046-021-02209-w.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1623_CR48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3892\/etm.2020.8723","volume":"20","author":"W Yu","year":"2020","unstructured":"Yu W, Shi Q, Wu C, Shen X, Chen L, Xu J. Promoter hypermethylation influences the suppressive role of long non-coding RNA MEG3 in the development of multiple myeloma. Exp Ther Med. 2020;20(1):637\u201345. https:\/\/doi.org\/10.3892\/etm.2020.8723.","journal-title":"Exp Ther Med."},{"issue":"3","key":"1623_CR49","doi-asserted-by":"publisher","first-page":"C684","DOI":"10.1152\/ajpcell.00348.2023","volume":"326","author":"L Yao","year":"2024","unstructured":"Yao L, et al. ALKHB5-demethylated lncRNA SNHG15 promotes myeloma tumorigenicity by increasing chromatin accessibility and recruiting H3K36me3 modifier SETD2. Am J Physiol Cell Physiol. 2024;326(3):C684\u201397. https:\/\/doi.org\/10.1152\/ajpcell.00348.2023.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1623_CR50","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.1038\/s41598-018-24701-8","volume":"8","author":"D Ronchetti","year":"2018","unstructured":"Ronchetti D, et al. A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma. Sci Rep. 8:6557. https:\/\/doi.org\/10.1038\/s41598-018-24701-8.","journal-title":"Sci Rep"},{"key":"1623_CR51","doi-asserted-by":"publisher","unstructured":"Qian Y, Shi L, Luo Z. Long non-coding RNAs in cancer: Implications for diagnosis, prognosis, and therapy. Front Med. 7. https:\/\/doi.org\/10.3389\/fmed.2020.612393.","DOI":"10.3389\/fmed.2020.612393"},{"issue":"7","key":"1623_CR52","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/14728222.2021.1938541","volume":"25","author":"M Montes","year":"2021","unstructured":"Montes M, Arnes L. lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer? Expert Opin Ther Targets. 25(7):521\u20138. https:\/\/doi.org\/10.1080\/14728222.2021.1938541.","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"1623_CR53","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","volume":"32","author":"N Amodio","year":"2018","unstructured":"Amodio N, et al. Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. Leukemia. 2018;32(9):1948\u201357. https:\/\/doi.org\/10.1038\/s41375-018-0067-3.","journal-title":"Leukemia"},{"issue":"10","key":"1623_CR54","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","volume":"32","author":"Y Hu","year":"2018","unstructured":"Hu Y, et al. Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Leukemia. 2018;32(10):2250\u201362. https:\/\/doi.org\/10.1038\/s41375-018-0104-2.","journal-title":"Leukemia"},{"issue":"1","key":"1623_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40364-023-00467-8","volume":"11","author":"J Hou","year":"2023","unstructured":"Hou J, Zhang G, Wang X, Wang Y, Wang K. Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance. Biomark Res. 11(1):23. https:\/\/doi.org\/10.1186\/s40364-023-00467-8.","journal-title":"Biomark Res"},{"issue":"8","key":"1623_CR56","doi-asserted-by":"publisher","first-page":"2300134","DOI":"10.1002\/ardp.202300134","volume":"356","author":"R Rocca","year":"2023","unstructured":"Rocca R, et al. Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening. Arch Pharm (Weinheim). 2023;356(8):2300134. https:\/\/doi.org\/10.1002\/ardp.202300134.","journal-title":"Arch Pharm (Weinheim)"},{"key":"1623_CR57","doi-asserted-by":"publisher","first-page":"106967","DOI":"10.1016\/j.leukres.2022.106967","volume":"123","author":"X Zang","year":"2022","unstructured":"Zang X, et al. LncRNA MEG3 promotes the sensitivity of bortezomib by inhibiting autophagy in multiple myeloma. Leuk Res. 123:106967. https:\/\/doi.org\/10.1016\/j.leukres.2022.106967.","journal-title":"Leuk Res"},{"issue":"6","key":"1623_CR58","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41375-020-01034-y","volume":"35","author":"A David","year":"2021","unstructured":"David A, et al. The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling. Leukemia. 2021;35(6):1710\u201321. https:\/\/doi.org\/10.1038\/s41375-020-01034-y.","journal-title":"Leukemia"},{"key":"1623_CR59","doi-asserted-by":"publisher","unstructured":"Shen Q, et al. Knockdown of lncRNA AL928768.3 inhibits multiple myeloma cell proliferation by inducing cell cycle arrest in G0\/G1 phase. Ann Transl Med. Feb. 2022;10(4). https:\/\/doi.org\/10.21037\/atm-21-6710.","DOI":"10.21037\/atm-21-6710"},{"issue":"2","key":"1623_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/stem.2925","volume":"37","author":"B Li","year":"2019","unstructured":"Li B, et al. HOXC10 regulates osteogenesis of mesenchymal stromal cells through interaction with its natural antisense transcript lncHOXC-AS3. Stem Cells. 2019;37(2):247\u201356. https:\/\/doi.org\/10.1002\/stem.2925.","journal-title":"Stem Cells."},{"issue":"4","key":"1623_CR61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood.2022018471","volume":"141","author":"X Agirre","year":"2023","unstructured":"Agirre X. RROL lncRNA role in multiple myeloma. Blood. 2023;141(4):328\u201330. https:\/\/doi.org\/10.1182\/blood.2022018471.","journal-title":"Blood."},{"issue":"10","key":"1623_CR62","doi-asserted-by":"publisher","first-page":"e1484981","DOI":"10.1080\/2162402X.2018.1484981","volume":"7","author":"L De Beck","year":"2018","unstructured":"De Beck L, et al. Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects. Oncoimmunology. 2018;7(10):e1484981.https:\/\/doi.org\/10.1080\/2162402X.2018.1484981","journal-title":"Oncoimmunology"},{"issue":"6","key":"1623_CR63","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1111\/bjh.16686","volume":"189","author":"N Li","year":"2020","unstructured":"Li N, et al. Addition of low-dose decitabine to bortezomib and dexamethasone as second-line therapy in multiple myeloma. Br J Haematol. 2020;189(6):e258\u201362. https:\/\/doi.org\/10.1111\/bjh.16686.","journal-title":"Br J Haematol"},{"issue":"1","key":"1623_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/j.seminhematol.2020.12.004","volume":"58","author":"J Khouri","year":"2021","unstructured":"Khouri J, et al. DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma. Semin Hematol. 58(1):45\u201355. https:\/\/doi.org\/10.1053\/j.seminhematol.2020.12.004.","journal-title":"Semin Hematol"},{"issue":"11","key":"1623_CR65","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.4161\/15592294.2014.983367","volume":"9","author":"S Mithraprabhu","year":"2014","unstructured":"Mithraprabhu S, Kalff A, Chow A, Khong T, Spencer A. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma. Epigenetics. 2014;9(11):1511\u201320. https:\/\/doi.org\/10.4161\/15592294.2014.983367.","journal-title":"Epigenetics."},{"issue":"1","key":"1623_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2021.5058","volume":"49","author":"L Zheng","year":"2022","unstructured":"Zheng L, Zhang A, Liu J, Liu M, Zhang Y. HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA\/Slug axis. Int J Mol Med. 49(1). https:\/\/doi.org\/10.3892\/ijmm.2021.5058.","journal-title":"Int J Mol Med"},{"issue":"7","key":"1623_CR67","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager T, Plch J, Stiborova M, Hrabeta J. Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci. 18(7):1414. https:\/\/doi.org\/10.3390\/ijms18071414.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1623_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/epi.27473","volume":"9","author":"VJ Peschansky","year":"2014","unstructured":"Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics. 2014;9(1):3\u201312. https:\/\/doi.org\/10.4161\/epi.27473.","journal-title":"Epigenetics"},{"issue":"6","key":"1623_CR69","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2018.03.068","volume":"173","author":"SW Cho","year":"2018","unstructured":"Cho SW, et al. Promoter of lncRNA gene PVT1 is a tumor suppressor DNA boundary element. Cell. 2018;173(6):1398\u20131412.e22. https:\/\/doi.org\/10.1016\/j.cell.2018.03.068.","journal-title":"Cell."},{"issue":"6","key":"1623_CR70","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/cancers12061458","volume":"12","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Teng H, Yao F, Yap S, Sun Y, Ma L. Challenges and strategies in ascribing functions to long noncoding rnas. Cancers. 2020;12(6):1458. https:\/\/doi.org\/10.3390\/cancers12061458.","journal-title":"Cancers"},{"key":"1623_CR71","doi-asserted-by":"publisher","unstructured":"Jiang C et al. Identifying and functionally characterizing tissue specific and ubiquitously expressed human lncRNAs. Oncotarget. 2016;7(6):7120-7133. https:\/\/doi.org\/10.18632\/oncotarget.6859","DOI":"10.18632\/oncotarget.6859"},{"key":"1623_CR72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13059-016-0880-9","volume":"17","author":"J Chen","year":"2016","unstructured":"Chen J, et al. Evolutionary analysis across mammals reveals distinct classes of long non-coding RNAs. Genome Biol. 2016;17:19. https:\/\/doi.org\/10.1186\/s13059-016-0880-9.","journal-title":"Genome Biol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-024-01623-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:59:36Z","timestamp":1737784776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-024-01623-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1007\/s11912-024-01623-5","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"12 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of\u00a0Interest"}},{"value":"This article does not contain any studies with\u00a0human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}